Modulating Antibody Functionality in Infectious Disease and Vaccination

Trends Mol Med. 2016 Nov;22(11):969-982. doi: 10.1016/j.molmed.2016.09.002. Epub 2016 Oct 15.

Abstract

Induction of pathogen-specific binding antibodies has long been considered a signature of protective immunity following vaccination and infection. The humoral immune response is a complex network of antibodies that target different specificities and drive different functions, collectively acting to limit and clear infection either directly, via pathogen neutralization, or indirectly, via pathogen clearance by the innate immune system. Emerging data suggest that not all antibody responses are equal, and qualitative features of antibodies may be key to defining protective immune profiles. Here, we review the most recent advances in our understanding of protective functional antibody responses in natural infection, vaccination, and monoclonal antibody therapeutics. Moreover, we highlight opportunities to augment or modulate antibody-mediated protection through enhancement of antibody functionality.

Keywords: ADCC; Fc receptors; HIV; antibodies; antibody glycosylation; vaccination.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Neutralizing / immunology*
  • Antibodies, Neutralizing / therapeutic use
  • Antibody Affinity
  • Communicable Disease Control / methods
  • Communicable Diseases / immunology*
  • Humans
  • Immunity, Humoral*
  • Immunity, Innate*
  • Vaccination / methods*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing